Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-23

FDA Approved: NITROFURANTOIN — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for nitrofurantoin filed by Rising Pharma Holdings, Inc., reflecting a change to the drug's labeling/indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrofurantoin (Nitrofurantoin)

Snippet

SUPPL AP for NITROFURANTOIN (NITROFURANTOIN)